Knowledge and practices of generalist and specialist physicians regarding drug therapy for acute myocardial infarction.
The respective roles of generalist and specialist physicians in the care of patients are currently a matter of debate.
Information is limited about the knowledge and practices of generalist and specialist physicians regarding conditions that both groups treat, such as myocardial infarction.
We therefore surveyed 1211 cardiologists, internists, and family practitioners in the states of New York and Texas about four treatments demonstrated by randomized clinical trials to be associated with improved survival after myocardial infarction (thrombolytic therapy, immediate and long-term use of aspirin, and long-term use of beta-blockers) and two treatments for which such evidence is lacking (diltiazem for patients with pulmonary congestion and prophylactic lidocaine).
Mots-clés Pascal : Infarctus, Myocarde, Aigu, Connaissance, Information, Enseignement, Spécialité médicale, Cardiologie, Médecin généraliste, Chimiothérapie, Traitement, Homme, Appareil circulatoire pathologie, Myocarde pathologie, Cardiopathie coronaire
Mots-clés Pascal anglais : Infarct, Myocardium, Acute, Knowledge, Information, Teaching, Medical specialty, Cardiology, General practitioner, Chemotherapy, Treatment, Human, Cardiovascular disease, Myocardial disease, Coronary heart disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0010093
Code Inist : 002B30A09. Création : 09/06/1995.